|
1
|
Chavan S, Bray F, Lortet-Tieulent J,
Goodman M and Jemal A: International variations in bladder cancer
incidence and mortality. Eur Urol. 66:59–73. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smith ZL and Guzzo TJ: Urinary markers for
bladder cancer. F1000Prime Rep. 5:212013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Calderaro J, Rebouissou S, de Koning L,
Masmoudi A, Hérault A, Dubois T, Maille P, Soyeux P, Sibony M, de
la Taille A, et al: PI3K/AKT pathway activation in bladder
carcinogenesis. Int J Cancer. 134:1776–1784. 2014. View Article : Google Scholar
|
|
4
|
Ching CB and Hansel DE: Expanding
therapeutic targets in bladder cancer: The PI3K/Akt/mTOR pathway.
Lab Invest. 90:1406–1414. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
López-Knowles E, Hernández S, Malats N,
Kogevinas M, Lloreta J, Carrato A, Tardón A, Serra C and Real FX:
PIK3CA mutations are an early genetic alteration associated with
FGFR3 mutations in superficial papillary bladder tumors. Cancer
Res. 66:7401–7404. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu X, Obata T, Khan Q, Highshaw RA, De
Vere White R and Sweeney C: The phosphatidylinositol-3 kinase
pathway regulates bladder cancer cell invasion. BJU Int.
93:143–150. 2004. View Article : Google Scholar
|
|
7
|
Oka N, Tanimoto S, Taue R, Nakatsuji H,
Kishimoto T, Izaki H, Fukumori T, Takahashi M, Nishitani M and
Kanayama HO: Role of phosphatidylinositol-3 kinase/Akt pathway in
bladder cancer cell apoptosis induced by tumor necrosis
factor-related apoptosis-inducing ligand. Cancer Sci. 97:1093–1098.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mukherjee N, Houston TJ, Cardenas E and
Ghosh R: To be an ally or an adversary in bladder cancer: The NF-κB
story has not unfolded. Carcinogenesis. 36:299–306. 2015.
View Article : Google Scholar
|
|
9
|
Guan Z, Ding C, Du Y, Zhang K, Zhu JN,
Zhang T, He D, Xu S, Wang X and Fan J: HAF drives the switch of
HIF-1α to HIF-2α by activating the NF-κB pathway, leading to
malignant behavior of T24 bladder cancer cells. Int J Oncol.
44:393–402. 2014. View Article : Google Scholar
|
|
10
|
Bennasroune A, Gardin A, Aunis D, Crémel G
and Hubert P: Tyrosine kinase receptors as attractive targets of
cancer therapy. Crit Rev Oncol Hematol. 50:23–38. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Folkman J: Role of angiogenesis in tumor
growth and metastasis. Semin Oncol. 29(Suppl 16): 15–18. 2002.
View Article : Google Scholar
|
|
12
|
Sparmann A and Bar-Sagi D: Ras-induced
interleukin-8 expression plays a critical role in tumor growth and
angiogenesis. Cancer Cell. 6:447–458. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Warner KA, Miyazawa M, Cordeiro MMR, Love
WJ, Pinsky MS, Neiva KG, Spalding AC and Nör JE: Endothelial cells
enhance tumor cell invasion through a crosstalk mediated by CXC
chemokine signaling. Neoplasia. 10:131–139. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zeng Q, Li S, Chepeha DB, Giordano TJ, Li
J, Zhang H, Polverini PJ, Nor J, Kitajewski J and Wang CY:
Crosstalk between tumor and endothelial cells promotes tumor
angiogenesis by MAPK activation of Notch signaling. Cancer Cell.
8:13–23. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Z, Dong Z, Lauxen IS, Filho MS and
Nör JE: Endothelial cell-secreted EGF induces epithelial to
mesenchymal transition and endows head and neck cancer cells with
stem-like phenotype. Cancer Res. 74:2869–2881. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ferrara N, Hillan KJ, Gerber HP and
Novotny W: Discovery and development of bevacizumab, an anti-VEGF
antibody for treating cancer. Nat Rev Drug Discov. 3:391–400. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shaulian E and Karin M: AP-1 as a
regulator of cell life and death. Nat Cell Biol. 4:E131–E136. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Fus LP and Górnicka B: Role of
angiogenesis in urothelial bladder carcinoma. Cent European J Urol.
69:258–263. 2016.PubMed/NCBI
|
|
20
|
Rajjayabun PH, Keegan PE, Lunec J and
Mellon JK: erbB receptor expression patterns in human bladder
cancer. Urology. 66:196–200. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nicholson RI, Gee JM and Harper ME: EGFR
and cancer prognosis. Eur J Cancer. 37(Suppl 4): pp. S9–S15. 2001,
View Article : Google Scholar
|
|
22
|
Plate KH, Breier G, Millauer B, Ullrich A
and Risau W: Up-regulation of vascular endothelial growth factor
and its cognate receptors in a rat glioma model of tumor
angiogenesis. Cancer Res. 53:5822–5827. 1993.PubMed/NCBI
|
|
23
|
Holmes K, Roberts OL, Thomas AM and Cross
MJ: Vascular endothelial growth factor receptor-2: Structure,
function, intracellular signalling and therapeutic inhibition. Cell
Signal. 19:2003–2012. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kaneko T, Zhang Z, Mantellini MG, Karl E,
Zeitlin B, Verhaegen M, Soengas MS, Lingen M, Strieter RM, Nunez G,
et al: Bcl-2 orchestrates a cross-talk between endothelial and
tumor cells that promotes tumor growth. Cancer Res. 67:9685–9693.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Richmond A: Nf-kappa B, chemokine gene
transcription and tumour growth. Nat Rev Immunol. 2:664–674. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miyake M, Hori S, Morizawa Y, Tatsumi Y,
Nakai Y, Anai S, Torimoto K, Aoki K, Tanaka N, Shimada K, et al:
CXCL1-mediated interaction of cancer cells with tumor-associated
macrophages and cancer-associated fibroblasts promotes tumor
progression in human bladder cancer. Neoplasia. 18:636–646. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tian YF, Tang K, Guan W, Yang T, Xu H,
Zhuang QY and Ye ZQ: OK-432 suppresses proliferation and metastasis
by tumor associated macrophages in bladder cancer. Asian Pac J
Cancer Prev. 16:4537–4542. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin C, Lin W, Yeh S, Li L and Chang C:
Infiltrating neutrophils increase bladder cancer cell invasion via
modulation of androgen receptor (AR)/MMP13 signals. Oncotarget.
6:43081–43089. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gunes S, Sullu Y, Yegin Z, Buyukalpelli R,
Tomak L and Bagci H: ErbB receptor tyrosine kinase family
expression levels in urothelial bladder carcinoma. Pathol Res
Pract. 209:99–104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Appert-Collin A, Hubert P, Crémel G and
Bennasroune A: Role of ErbB receptors in cancer cell migration and
invasion. Front Pharmacol. 6:2832015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gately K, Forde L, Cuffe S, Cummins R, Kay
EW, Feuerhake F and O'Byrne KJ: High coexpression of both EGFR and
IGF1R correlates with poor patient prognosis in resected
non-small-cell lung cancer. Clin Lung Cancer. 15:58–66. 2014.
View Article : Google Scholar
|
|
32
|
Lee HJ, Seo AN, Kim EJ, Jang MH, Kim YJ,
Kim JH, Kim SW, Ryu HS, Park IA, Im SA, et al: Prognostic and
predictive values of EGFR overexpression and EGFR copy number
alteration in HER2-positive breast cancer. Br J Cancer.
112:103–111. 2015. View Article : Google Scholar :
|
|
33
|
Day KC, Lorenzatti Hiles G, Kozminsky M,
Dawsey SJ, Paul A, Broses LJ, Shah R, Kunja LP, Hall C, Palanisamy
N, et al: HER2 and EGFR overexpression support metastatic
progression of prostate cancer to bone. Cancer Res. 77:74–85. 2017.
View Article : Google Scholar :
|
|
34
|
Lipponen P and Eskelinen M: Expression of
epidermal growth factor receptor in bladder cancer as related to
established prognostic factors, oncoprotein (c-erbB-2, p53)
expression and long-term prognosis. Br J Cancer. 69:1120–1125.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lo HW and Hung MC: Nuclear EGFR signalling
network in cancers: Linking EGFR pathway to cell cycle progression,
nitric oxide pathway and patient survival. Br J Cancer. 94:184–188.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fine BA, Valente PT, Feinstein GI and Dey
T: VEGF, flt-1, and KDR/flk-1 as prognostic indicators in
endometrial carcinoma. Gynecol Oncol. 76:33–39. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sato Y, Kanno S, Oda N, Abe M, Ito M,
Shitara K and Shibuya M: Properties of two VEGF receptors, Flt-1
and KDR, in signal transduction. Ann NY Acad Sci. 902:201–205;
discussion 205-207. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Strieter RM, Polverini PJ, Kunkel SL,
Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A,
Marriott D, et al: The functional role of the ELR motif in CXC
chemokine-mediated angiogenesis. J Biol Chem. 270:27348–27357.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Addison CL, Daniel TO, Burdick MD, Liu H,
Ehlert JE, Xue YY, Buechi L, Walz A, Richmond A and Strieter RM:
The CXC chemokine receptor 2, CXCR2, is the putative receptor for
ELR+ CXC chemokine-induced angiogenic activity. J
Immunol. 165:5269–5277. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Subauste MC and Proud D: Effects of tumor
necrosis factor-alpha, epidermal growth factor and transforming
growth factor-alpha on interleukin-8 production by, and human
rhinovirus replication in, bronchial epithelial cells. Int
Immunopharmacol. 1:1229–1234. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Richter A, O'Donnell RA, Powell RM,
Sanders MW, Holgate ST, Djukanović R and Davies DE: Autocrine
ligands for the epidermal growth factor receptor mediate
interleukin-8 release from bronchial epithelial cells in response
to cigarette smoke. Am J Respir Cell Mol Biol. 27:85–90. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Moscova M, Marsh DJ and Baxter RC: Protein
chip discovery of secreted proteins regulated by the
phosphatidylinositol 3-kinase pathway in ovarian cancer cell lines.
Cancer Res. 66:1376–1383. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yeudall WA, Vaughan CA, Miyazaki H,
Ramamoorthy M, Choi MY, Chapman CG, Wang H, Black E, Bulysheva AA,
Deb SP, et al: Gain-of-function mutant p53 upregulates CXC
chemokines and enhances cell migration. Carcinogenesis. 33:442–451.
2012. View Article : Google Scholar
|
